Panacea Biotec Pharma Limited
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- India
- Registered address
- Pharma Block, Malpur, Baddi, Solan, Himachal Pradesh 173205, India (IND)
- Operations here
- analysismanufacture
- FDA identifiers
- FEI 3007187282 · DUNS 857979552
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- OAIDrug Quality Assurance2023-10-12
- OAIDrug Quality Assurance2022-06-08
- NAIDrug Quality Assurance2019-04-30
- VAIDrug Quality Assurance2017-12-13
- VAIDrug Quality Assurance2015-12-11
- VAIDrug Quality Assurance2013-10-25
- NAIDrug Quality Assurance2012-09-07
- NAIDrug Quality Assurance2009-11-13
Drugs this plant is listed as making
4 distinct drugs across 16 products name this site in their FDA label.
- Azacitidinein shortagePanacea Biotec Limited
- PrasugrelApotex Corp.
- rizatriptan benzoateBionpharma Inc.,
- TacrolimusJubilant Cadista Pharmaceuticals Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.